23 Jumada I 1446 - 24 November 2024
    
Sign up for newsletter
Eye of Riyadh

8th Pink Caravan Ride Registers 7,795 Free Breast 
Examinations Nationwide
Healthcare | Friday 23 March, 2018 1:41 am
It is not uncommon for Pink Caravan Ride – the pan-UAE breast cancer awareness campaign, which paints all seven emirates pink with awareness once every year – to supersede its achievements with each passing edition. A living testament of the feats pure grit and determination to bring...
Ebsar Foundation seeks TVTC's help to give job training to the visually impaired
Healthcare | Wednesday 21 March, 2018 4:39 am
The Ebsar Foundation, a non-profit organization that supports the visually challenged, has asked the Technical and Vocational Training Corporation (TVTC) to conduct training programs to qualify the visually impaired members of society for the job market and issue them accredited...
Long-awaited specialist hospital opens in Hail
Healthcare | Tuesday 20 March, 2018 6:45 am
Emir of Hail Prince Abdulaziz Bin Saad formally opened King Salman Specialist Hospital in this northern city in the presence of Health Minister Tawfiq Al-Rabiah and other top officials. The hospital, with a capacity of 500 beds, will provide healthcare to some 700,000 residents of the city. The...
Nahdi Pharmacies Mark the International Women's Day & Mother Day With a Campaign
Healthcare | Sunday 18 March, 2018 12:31 pm
In every March each year, there are specific days designated for women and celebrated in many countries around the globe, including the International Women's Day and the Mother's Day. Celebrating such a joyful occasion, Nahdi Pharmacies launched the campaign "You're the Most...
Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom’s healthcare sector
Healthcare | Wednesday 14 March, 2018 5:17 pm
The Saudi Arabian Ministry of Health and GE (NYSE: GE) have delivered the first phase of a landmark Memorandum of Understanding (MOU) focused on digital transformation in healthcare, signed in May 2017 in the presence of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud. In...
AbbVie named the best pharmaceutical company to work for in Saudi Arabia for the fourth year in a row
Healthcare | Wednesday 14 March, 2018 12:17 pm
AbbVie, a global research and development-based biopharmaceutical company, announced today that it has been named the top pharmaceutical company to work for in Saudi Arabia by Great Place to Work® for the fourth year in a row. Moreover, AbbVie went up one place and ranked second place in 2017...
UAE’s first ICU Symposium attracts over 150 of GCCs top healthcare professionals
Healthcare | Monday 12 March, 2018 12:45 pm
The Cambridge ICU Rehab Symposium 2018, organized by Cambridge Medical and Rehabilitation Center, UAE’s leading rehabilitation and post-acute care provider, was held at The Intercontinental Hotel, Dubai Festival City. The symposium, which was attended by over 150 healthcare professionals from ...
Pink Caravan Ride Fixed Clinics Extend Deadline until March 15
Healthcare | Monday 12 March, 2018 12:05 pm
In a bid to continue its efforts to reach out to heighten people’s awareness about the dangers of breast cancer and the importance of early detection in mitigating risks, the Pink Caravan Ride’s eighth annual edition which concluded last week has announced that the fixed clinics in...
BinSina Pharmacy aggressive expansion plan on course as 15 new outlets set to launch in the UAE
Healthcare | Monday 12 March, 2018 10:55 am
United Arab Emirates’ first licensed pharmacy, BinSina, announced today plans to open 15 new outlets in the country as it seeks to cement its leadership position as a major player in the region offering a wide range of  pharma, skincare, beauty, lifestyle, supplements and vitamins...
Alirocumab reduced risk of major adverse cardiovascular events by 24% and was associated with a 29% lower risk of death overall
Healthcare | Monday 12 March, 2018 9:58 am
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the risk of major adverse cardiovascular events (MACE) in patients who had suffered a recent acute coronary syndrome (ACS)...
ADD TO EYE OF Riyadh
MOST POPULAR